Vol.

No.

April 03, 2020Apr 03, 2020

Free

DOWNLOAD THE PDF

Friending viral foes: The Zika story and (perhaps) lessons for COVID-19

Cover Story

COVID-19 & Cancer Free Guest Editorial

Friending viral foes: The Zika story and (perhaps) lessons for COVID-19

By Scott M. Lippman

On a recent call with directors of cancer centers, NCI Director Ned Sharpless reminded us that quarantines present opportunities for scientists to think deeply.

Editorial Free

We are in this together

By Paul Goldberg

Free Guest Editorial

What cancer immunologists are doing about COVID-19

By Rachel Humphrey

Conversation with The Cancer Letter Free

A COVID-19 update from New York: "The only thing I hear at night now is the wail of ambulances"

By Matthew Bin Han Ong

Conversation with The Cancer Letter COVID-19 & Cancer Free

As Italy's COVID-19 incidence curve flattens, Curigliano sees lessons for the U.S.

By Alexandria Carolan

Clinical COVID-19 & Cancer Free Trials & Tribulations

COVID-19 and cancer: Ethical dilemmas in immune checkpoint blockade

By Allison Betof Warner

COVID-19 Updates

AACR to Congress: Act on PPE, ventilator and testing shortages

Advocacy organizations: Stop threatening health care workers who speak out about lack of PPE

American College of Surgeons: Health care workers need PPE

CPRIT suspends first cycle of awards for FY21

Scott Gottlieb: A road map for navigating COVID-19 in the U.S.

CMS addresses surge of COVID-19 patients

COA thanks CMS for telehealth expansion

LLS, partners commit $4.5M for blood cancer patients impacted by COVID-19

PharmaMar submits phase II clinical trial of Aplidin treatment of COVID-19 to the Spanish Medicines Agency

Study: Patients with new-onset digestive symptoms after possible COVID-19 contact should be suspected for the illness

Convalescent plasma donations to be collected by Versiti Blood Centers to treat COVID-19 patients

Metastatic breast cancer patient tests negative for COVID-19

FAQs and Guidances

Clinical Roundup

Keytruda significantly improves PFS as first-line treatment in colorectal cancer indication

Phase III cancer vaccine trial meets primary endpoint

Caris Life Sciences develops AI-powered predictor of chemotherapy sensitivity in MCC

Drugs & Targets

FDA approves Imfinzi for ES-SCLC

EMA grants positive opinion to Adcetris combination in lymphoma indication

NCI Trials

NCI Trials for April 2020

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE